Aliki Xochelli, MD, PhD is a Postdoctoral Researcher at the Center for Research and Technology Hellas (CERTH), Greece. She has authored and co-authored over 30 peer reviewed research papers.
Speaking on precision medicine in CLL and lymphoma
Dr Xochelli’s work focusses on chronic lymphocytic lymphoma (CLL) and T-cells. Her most recent published papers include research into how myeloid-derived suppressor cell subtypes influence T-cell function, the influence of end-stage renal disease on CD28 expression and T-cell immunity, and an overview of the Greek study, ERIC CLL, that assessed patient’s knowledge of CLL.